Apogee Therapeutics, Inc. Common Stock Balance Sheet
Concept
Total Assets
Current Assets
Cash, Cash Equivalents & Short Term Investments
Cash & Equivalents
Other Short Term Investments
Receivables
Inventory
Other Current Assets
Total non-current assets
Property, Plant & Equipment
Long-Term Investments
Total Liabilities
Current Liabilities
Accounts Payable
Current Debt
Deferred Revenue
Total Non Current Liabilities Net Minority Interest
Long-Term Debt
Other Long-Term Liabilities
Common Stock Equity
Working Capital
Invested Capital
Total Debt
Net Debt
2023
2022
401M
398M
395M
0M
277M
0M
0M
3M
3M
0M
0M
21M
21M
2M
1M
0M
1M
0M
0M
380M
378M
504M
2M
-116M
152M
152M
152M
0M
0M
0M
0M
0M
0M
0M
0M
10M
10M
0M
0M
0M
0M
0M
0M
-40M
142M
142M
0M
-152M
Concept
Total Assets
Current Assets
Cash, Cash Equivalents & Short Term Investments
Cash & Equivalents
Other Short Term Investments
Receivables
Inventory
Other Current Assets
Total non-current assets
Property, Plant & Equipment
Long-Term Investments
Total Liabilities
Current Liabilities
Accounts Payable
Current Debt
Deferred Revenue
Total Non Current Liabilities Net Minority Interest
Long-Term Debt
Other Long-Term Liabilities
Common Stock Equity
Working Capital
Invested Capital
Total Debt
Net Debt
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
401M
398M
395M
0M
277M
0M
0M
3M
3M
0M
0M
21M
21M
2M
1M
0M
1M
0M
0M
380M
378M
504M
2M
-116M
426M
426M
423M
0M
235M
0M
0M
1M
0M
0M
0M
17M
17M
1M
0M
0M
0M
0M
0M
501M
409M
501M
0M
-188M
131M
131M
125M
0M
0M
0M
0M
6M
3M
0M
0M
195M
18M
11M
0M
0M
177M
0M
0M
-71M
113M
113M
0M
-125M
142M
142M
141M
0M
0M
0M
0M
1M
0M
0M
0M
11M
11M
1M
0M
0M
0M
0M
0M
-52M
131M
131M
0M
-141M
152M
152M
152M
0M
0M
0M
0M
0M
0M
0M
0M
10M
10M
0M
0M
0M
0M
0M
0M
-40M
142M
142M
0M
-152M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M
0M